StockDrifts LogoStockDrifts

Prosight Management 13F Portfolio

Portfolio Manager
Prosight Management LP
Performance
+0.70% (2026 Q2)
AUM (13F)
$580.35M
# of Holdings
36
Performance Rank
Allocation (Top 20)
92.32%
Latest filing
Q2 2026

Prosight Management LP Holdings Map

Top 36 Prosight Management LP Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
GLPG
LAKEFRONT BIOTHERAPEUTICS NV
10.56%2.04M$61.3M
+31.83%(+493.34K)
2025-Q2: 1.77M shares2025-Q3: 1.15M shares2025-Q4: 1.07M shares2026-Q1: 1.55M shares2026-Q2: 2.04M shares
$32.74(-14.70%)
2026-06-30
JANX
JANUX THERAPEUTICS INC
10.07%3.80M$58.4M
+7.17%(+254.48K)
2025-Q2: 853.9K shares2025-Q3: 865.4K shares2025-Q4: 2.39M shares2026-Q1: 3.55M shares2026-Q2: 3.80M shares
$21.82(-26.13%)
2026-06-30
NKTR
NEKTAR THERAPEUTICS
9.74%810.0K$56.5M
+10.20%(+75.00K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 554.6K shares2026-Q1: 735.0K shares2026-Q2: 810.0K shares
$52.93(+39.55%)
2026-06-30
BSX
BOSTON SCIENTIFIC CORP
9.34%1.27M$54.2M
+59.67%(+474.73K)
2025-Q2: 0 shares2025-Q3: 76.1K shares2025-Q4: 210.0K shares2026-Q1: 795.5K shares2026-Q2: 1.27M shares
$72.49(-28.50%)
2026-06-30
STTK
SHATTUCK LABS INC
7.12%5.96M$41.3M
+19.05%(+953.44K)
2025-Q2: 6.64M shares2025-Q3: 5.45M shares2025-Q4: 2.38M shares2026-Q1: 5.00M shares2026-Q2: 5.96M shares
$5.35(+38.68%)
2026-06-30
INSM
INSMED INC
6.9%375.6K$40.0Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 375.6K shares
$129.97(-4.79%)
2026-06-30
ALNY
ALNYLAM PHARMACEUTICALS INC
5.09%98.1K$29.5M
+29.05%(+22.08K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 17.1K shares2026-Q1: 76.0K shares2026-Q2: 98.1K shares
$362.63(-36.95%)
2026-06-30
SNDX
SYNDAX PHARMACEUTICALS INC
4.52%1.20M$26.2M
+55.84%(+430.00K)
2025-Q2: 1.08M shares2025-Q3: 1.00M shares2025-Q4: 665.0K shares2026-Q1: 770.0K shares2026-Q2: 1.20M shares
$19.34(+2.59%)
2026-06-30
KURA
KURA ONCOLOGY INC
3.82%2.02M$22.2M
-39.76%(-1.33M)
2025-Q2: 3.18M shares2025-Q3: 2.76M shares2025-Q4: 2.53M shares2026-Q1: 3.36M shares2026-Q2: 2.02M shares
$9.38(+15.82%)
2026-06-30
ALKS
ALKERMES PLC
3.56%394.4K$20.7M
-23.22%(-119.24K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 513.6K shares2026-Q2: 394.4K shares
$31.67(+54.91%)
2026-06-30

About Prosight Management LPโ€™s portfolio

Prosight Management LP reports $580.35M in US-listed equity holdings across 36 positions in its most recent 13F filing. Its largest disclosed positions are GLPG (10.6%), JANX (10.1%) and NKTR (9.7%). The top 20 holdings account for 92.32% of reported assets. Its disclosed equity book has returned +15.55% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
GLPG โ€” 10.6% ($61.26M)JANX โ€” 10.1% ($58.44M)NKTR โ€” 9.7% ($56.55M)BSX โ€” 9.3% ($54.22M)STTK โ€” 7.1% ($41.35M)INSM โ€” 6.9% ($40.05M)ALNY โ€” 5.1% ($29.53M)SNDX โ€” 4.5% ($26.23M)KURA โ€” 3.8% ($22.18M)ALKS โ€” 3.6% ($20.66M)Other โ€” 29.3% ($169.90M)
71%in top 10
  • GLPG10.6%
  • JANX10.1%
  • NKTR9.7%
  • BSX9.3%
  • STTK7.1%
  • INSM6.9%
  • ALNY5.1%
  • SNDX4.5%
  • KURA3.8%
  • ALKS3.6%
  • Other29.3%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
5
INSMINSMED INC6.9%
MLYSMINERALYS THERAPEUTICS INC2.1%
OPCHOPTION CARE HEALTH INC1.0%
PFEPFIZER INC0.6%
+1 opened
Added to
16
BSXBOSTON SCIENTIFIC CORP+59.7%
IRTCIRHYTHM HOLDINGS INC+1555.0%
GLPGLAKEFRONT BIOTHERAPEUTICS NV+31.8%
SNDXSYNDAX PHARMACEUTICALS INC+55.8%
+12 more
Trimmed
15
PRCTPROCEPT BIOROBOTICS CORP-86.2%
MGTXMEIRAGTX HLDGS PLC-96.6%
WGSGENEDX HOLDINGS CORP-83.7%
KURAKURA ONCOLOGY INC-39.8%
+11 more

Unlock alerts, watchlists & AI chat

Sign up free to track Prosight Management LP, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Prosight Management LPโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1617201). View Prosight Management LPโ€™s 13F filings on SEC

More 13F analyses

View all